4.5 Article

A versatile partner of eukaryotic protein complexes that is involved in multiple biological processes:: Kti11/Dph3

Journal

MOLECULAR MICROBIOLOGY
Volume 69, Issue 5, Pages 1221-1233

Publisher

WILEY
DOI: 10.1111/j.1365-2958.2008.06350.x

Keywords

-

Ask authors/readers for more resources

The Kluyveromyces lactis killer toxin zymocin insensitive 11 (KTI11) gene from Saccharomyces cerevisiae is allelic with the diphthamide synthesis 3 (DPH3) locus. Here, we present evidence that the KTI11 gene product is a versatile partner of proteins and operates in multiple biological processes. Notably, Kti11 immune precipitates contain Elp2 and Elp5, two subunits of the Elongator complex which is involved in transcription, tRNA modification and zymocin toxicity. KTI11 deletion phenocopies Elongator-minus cells and causes antisuppression of nonsense and missense suppressor tRNAs (SUP4, SOE1), zymocin resistance and protection against the tRNase attack of zymocin. In addition and unlike Elongator mutants, kti11 mutants resist diphtheria toxin (DT), protect against ADP-ribosylation of eukaryotic translation elongation factor 2 (eEF2) by DT and induce resistance against sordarin, an eEF2 poisoning antifungal. The latter phenotype applies to all diphthamide mutants (dph1-dph5) tested and Kti11/Dph3 physically interacts with diphthamide synthesis factors Dph1 and Dph2, presumably as part of a trimeric complex. Moreover, we present a separation of function mutation in KTI11, kti11-1, which dissociates zymocin resistance from DT sensitivity. It encodes a C-terminal Kti11 truncation that almost entirely abolishes Elongator interaction without affecting association with Kti13, another Kti11 partner protein.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cardiac & Cardiovascular Systems

Going the Long Noncoding RNA Way Toward Cardiac Regeneration: Mapping Candidate Long Noncoding RNA Controllers of Regeneration

David de Gonzalo-Calvo, Christian Baer

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

Sandor Batkai, Celina Genschel, Janika Viereck, Steffen Rump, Christian Baer, Tobias Borchert, Denise Traxler, Martin Riesenhuber, Andreas Spannbauer, Dominika Lukovic, Katrin Zlabinger, Ena Hasimbegovic, Johannes Winkler, Rita Garamvolgyi, Sonja Neitzel, Mariann Gyoengyoesi, Thomas Thum

Summary: In a chronic model of post-myocardial infarction heart failure, monthly administration of CDR132L improved cardiac function, reversed cardiac remodelling, and ameliorated diastolic function, indicating its safety and therapeutic efficacy for chronic heart failure treatment.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Circulating cardiovascular microRNAs in critically ill COVID-19 patients

Ankita Garg, Benjamin Seeliger, Anselm A. Derda, Ke Xiao, Anika Gietz, Kristian Scherf, Kristina Sonnenschein, Isabell Pink, Marius M. Hoeper, Tobias Welte, Johann Bauersachs, Sascha David, Christian Bar, Thomas Thum

Summary: Elevated levels of cardiovascular and inflammatory microRNAs were observed in critically ill COVID-19 patients, suggesting a specific response and cardiac involvement of COVID-19. MiR profiles showed potential for differentiating between severe COVID-19 and Influenza-ARDS patients.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology

Katharina Schimmel, Stevan D. Stojanovic, Cheng-Kai Huang, Mira Jung, Martin H. Meyer, Ke Xiao, Lea Grote-Levi, Christian Baer, Angelika Pfanne, Saskia Mitzka, Annette Just, Robert Geffers, Katharina Bock, Franziska Kenneweg, Felix Kleemiss, Christine S. Falk, Jan Fiedler, Thomas Thum

Summary: This study identified miR-20a-5p and miR-132-3p as crucial regulators of cardiac fibrosis pathways in an in vitro model. Functional screening and deep sequencing revealed their pro-fibrotic nature and involvement in pathways related to autophagy and detoxification of reactive oxygen species.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

Article Biotechnology & Applied Microbiology

Telomerase therapy attenuates cardiotoxic effects of doxorubicin

Shambhabi Chatterjee, Teresa Hofer, Alessia Costa, Dongchao Lu, Sandor Batkai, Shashi Kumar Gupta, Emiliano Bolesani, Robert Zweigerdt, Diego Megias, Katrin Streckfuss-Boemeke, Christina Brandenberger, Thomas Thum, Christian Baer

Summary: Telomerase overexpression can serve as a therapeutic strategy for preventing doxorubicin-induced cardiotoxicity, protecting the heart from doxorubicin-induced damage and restoring cardiac function. Telomerase in cells has antioxidant and anti-apoptotic effects, and achieves protection by regulating mitochondrial morphology and function.

MOLECULAR THERAPY (2021)

Article Cardiac & Cardiovascular Systems

Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction

Moritz Biener, Evangelos Giannitsis, Thomas Thum, Christian Baer, Alessia Costa, Thomas Andrzejewski, Kiril M. Stoyanov, Mehrshad Vafaie, Benjamin Meder, Hugo A. Katus, David de Gonzalo-Calvo, Matthias Mueller-Hennessen

Summary: This study evaluated the diagnostic value of 11 microRNAs for NSTEMI, finding that a panel of three microRNAs could be associated with NSTEMI diagnosis, but did not improve diagnostic accuracy compared to the hs-cTnT reference standard.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2021)

Review Cardiac & Cardiovascular Systems

Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration

Hannah J. Hunkler, Sonja Gross, Thomas Thum, Christian Baer

Summary: Myocardial infarction leads to the loss of cardiomyocytes and heart failure. The only curative treatment for heart failure currently is heart transplantation, but it has limitations. Cellular reprogramming and defined differentiation protocols offer new possibilities for cell therapy, and non-coding RNAs have been shown to regulate these processes.

CARDIOVASCULAR RESEARCH (2022)

Article Medical Laboratory Technology

Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department

Moritz Biener, Evangelos Giannitsis, Thomas Thum, Christian Bar, Kiril M. Stoyanov, Christian Salbach, David De Gonzalo-Calvo, Norbert Frey, Matthias Mueller-Hennessen

Summary: The study found that miR-21-5p and miR-122-5p can predict the survival rate of patients with cardiovascular diseases in the emergency department, but do not add prognostic information to hs-cTnT.

CLINICAL BIOCHEMISTRY (2022)

Review Cardiac & Cardiovascular Systems

Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration

Alessia Costa, Sarah Cushman, Bernhard J. Haubner, Anselm A. Derda, Thomas Thum, Christian Baer

Summary: Myocardial injury often leads to heart failure due to the loss and insufficient regeneration of resident cardiomyocytes. The low regenerative potential of the mammalian heart is one of the main drivers of heart failure progression. Newborn mice serve as a valuable model for studying cardiac regeneration as they retain full regenerative capacity. Understanding the molecular mechanisms of cardiac regeneration in animal models is crucial for developing novel therapeutic strategies in regenerative medicine.

BASIC RESEARCH IN CARDIOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models

Elisa Mohr, Thomas Thum, Christian Baer

Summary: In vitro modeling of the heart is a challenging task in cardiovascular research. Three-dimensional cultivation methods have emerged as a solution to overcome the limitations of traditional two-dimensional cultivation. These methods aim to study the fundamental features of the heart and have great potential in disease research, drug screening, and regenerative therapy. However, there is a need for continuous improvement and adaptation to address limitations such as cardiomyocyte maturation and vascularization.

EUROPEAN JOURNAL OF HEART FAILURE (2022)

Article Multidisciplinary Sciences

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

Nadire Duru, Nisha R. Pawar, Erik W. Martin, Marguerite S. Buzza, Gregory D. Conway, Rena G. Lapidus, Shihui Liu, Jocelyn Reader, Gautam G. Rao, Dana M. Roque, Stephen H. Leppla, Toni M. Antalis

Summary: This study presents a novel anticancer strategy using engineered anthrax toxin that can selectively activate malignant tumor cells and induce cell death. The toxin exhibits cytotoxicity towards ovarian tumor cell lines and tumor spheroids derived from patient ascites. Preclinical studies demonstrate tumor regression in various in vivo ovarian cancer models without adverse side effects, supporting its potential for clinical evaluation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Cardiac & Cardiovascular Systems

Circular RNAs at the intersection of cancer and heart disease: potential therapeutic targets in cardio-oncology

Dimyana Neufeldt, Sarah Cushman, Christian Baer, Thomas Thum

Summary: Considerable progress has been made in managing cancer, but the discovery of previously unknown adverse events poses challenges to treatment. The close relationship between cardiovascular diseases and cancer underscores the need for interdisciplinary study. Non-coding RNAs, particularly circular RNAs, are emerging as potential targets for the simultaneous treatment of cardiac dysfunction and cancer in the field of cardio-oncology.

CARDIOVASCULAR RESEARCH (2023)

Article Multidisciplinary Sciences

ERK and c-Myc signaling in host-derived tumor endothelial cells is essential for solid tumor growth

Zehua Zuo, Jie Liu, Zhihao Sun, Yu-Wei Cheng, Michael Ewing, Thomas H. Bugge, Toren Finkel, Stephen H. Leppla, Shihui Liu

Summary: The current antitumor microenvironment strategies have limited efficacy due to poor understanding of the roles and contributions of tumor stromal cells in tumor development. Researchers have developed a versatile in vivo delivery system for an anthrax toxin protein, which allows for clear genetic evaluation of individual tumor stromal elements. The findings reveal the specific contribution of tumor endothelial cells (ECs) to the antitumor activity of the toxin, highlighting the importance of the MEK-ERK-c-Myc central metabolic axis in tumor ECs for tumor progression.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Physiology

A single session of EMS training induces long-lasting changes in circulating muscle but not cardiovascular miRNA levels: a randomized crossover study

Sinje Biss, Marc Teschler, Melina Heimer, Thomas Thum, Christian Baer, Frank C. Mooren, Boris Schmitz

Summary: This study aimed to evaluate the long-term effects of EMS on circulating miRNA levels. The results showed that a single EMS session induces specific long-lasting changes in miR-206 and miR-133a involved in muscle proliferation and differentiation, but does not affect cardiovascular miRNAs.

JOURNAL OF APPLIED PHYSIOLOGY (2023)

Article Multidisciplinary Sciences

A potent tumor-selective ERK pathway inactivator with high therapeutic index

Zehua Zuo, Jie Liu, Zhihao Sun, Rachel Silverstein, Meijuan Zou, Toren Finkel, Thomas H. Bugge, Stephen H. Leppla, Shihui Liu

Summary: This article introduces a reengineered anthrax toxin-based tumor-selective MEK inactivator that exhibits potent activity against solid tumors and has a high therapeutic index. The specificity of the inactivator has been improved to only target the ERK pathway, greatly reducing off-target toxicity. Engineered bacterial toxins can be modified to have significant therapeutic effects with high therapeutic index.

PNAS NEXUS (2022)

No Data Available